Zobrazeno 1 - 10
of 242
pro vyhledávání: '"Giuseppe, Masera"'
Autor:
Nicoletta Masera, Valentina Decimi, Luisa Tavecchia, Marietta Capra, Giovanni Cazzaniga, Andrea Biondi, Giuseppe Masera
Publikováno v:
Clinical Management Issues, Vol 4, Iss 2, Pp 65-70 (2010)
We report the case of a 22-year-old woman from Albania, with thalassaemia major, in severe clinical condition who could no longer be transfused due to the occurrence of severe, acute, post-transfusional reactions. After 10 years of treatment, she fai
Externí odkaz:
https://doaj.org/article/8d0c8b288e7149ed92b69b86fd13bc51
Autor:
Francesca Lanfranconi, Luca Pollastri, Alessandra Ferri, Donatella Fraschini, Giuseppe Masera, Giuseppe Miserocchi
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99282 (2014)
BACKGROUND: Separating out the effects of cancer and treatment between central and peripheral components of the O2 delivery chain should be of interest to clinicians for longitudinal evaluation of potential functional impairment in order to set appro
Externí odkaz:
https://doaj.org/article/494877908e104d728c1e7be2fa60037c
Publikováno v:
Journal of Psychosocial Oncology. 32:576-601
This study investigated memories of childhood leukemia conveyed by survivors belonging to a Latin culture, exploring whether benefit findings was spontaneously reported, as by non-Latin survivors. Three hundred patients previously treated for leukemi
Autor:
Fiorina Casale, Elena Barisone, Gaetano La Barba, Anna Maria Testi, Daniela Silvestri, Maurizio Aricò, Concetta Micalizzi, Paolo Tamaro, Giuseppe Basso, Rosanna Parasole, Lucia Dora Notarangelo, Carmelo Rizzari, Maria Grazia Valsecchi, Ottavio Ziino, Valentino Conter, Antonella Colombini, Maria Caterina Putti, Marco Zecca, Luca Lo Nigro, Franco Locatelli, Giuseppe Masera, Andrea Biondi, Nicola Santoro, Gabriella Casazza, Andrea Pession
Publikováno v:
Blood. 123:1470-1478
The outcome of high-risk (HR) Acute Lymphoblastic Leukemia (ALL) patients enrolled in AIEOP-BFM ALL 2000 study (NCT00613457) in Italy is described. Overall, 1999 Philadelphia negative ALL patients entered the study. HR criteria were: minimal residual
Autor:
C Arrigo, Ettore Biagi, Giuseppe Masera, A. Riva, P F Marchi, Attilio Rovelli, G. Marraro, Cornelio Uderzo
Publikováno v:
Supportive Care in Cancer
Pulmonary thromboembolism (PTE) in leukemic children undergoing intensive chemotherapy should be promptly recognized so that specific therapy can be started. Our experience with the two cases reported here has led us to propose guidelines for the tre
Autor:
Daniela Silvestri, Maria Grazia Valsecchi, Valentino Conter, Carlos Pacheco, Mercedes Arguello, Franco Cavalli, Giovanna Lucchini, Fulgencio Baez Lacayo, Andrea Biondi, Andronica Flores, Gianni Tognoni, Alberto Malta, Giuseppe Masera
Publikováno v:
Pediatric Blood & Cancer. 61:827-832
Background The aim of this paper is to describe the results of acute lymphoblastic leukemia (ALL) treatment in Nicaragua from 1995 to 2005 in the context of an international cooperation program. Procedures Patients
Autor:
Erica Brivio, Miguel Bonilla, Ligia Fu, Scott C. Howard, Roberto Vasquez, C. Pacheco Espinoza, Ronald D. Barr, L.F. Baez Lacayo, Emanuela Rossi, R. Batista, Armando Peña, Maria Grazia Valsecchi, Valentino Conter, Roxana Martinez, J.M. Carrillo, Raul C. Ribeiro, Andrea Biondi, Marta Navarrete, Hilze Rodriguez, Giuseppe Masera
Publikováno v:
Pediatric Blood & Cancer. 61:803-809
Background Five Asociacion de Hemato-Oncologia de Centroamerica (AHOPCA) countries have used an adapted BFM-based protocol for childhood acute lymphoblastic leukemia (ALL). Procedure In the AHOPCA-ALL 2008 protocol, patients were stratified by age, w
Autor:
Armando Peña, Franco Cavalli, Fulgencio Baez, Maria Grazia Valsecchi, Carlos Rodriguez-Galindo, Andrea Biondi, Federico Antillón Klussmann, Valentino Conter, Marta Navarrete, Belgica Moreno, Giuseppe Masera, Rosa Nieves, Scott C. Howard, Pedro A. de Alarcon, Raul C. Ribeiro, Ronald D. Barr, Miguel Bonilla, Gianni Tognoni, George Velez
Publikováno v:
Pediatric Blood & Cancer. 61:345-354
Bridging the survival gap for children with cancer, between those (the great majority) in low and middle income countries (LMIC) and their economically advantaged counterparts, is a challenge that has been addressed by twinning institutions in high i
Publikováno v:
Klinische Pädiatrie. 225:S57-S61
Autor:
Luis Alberto Malta, Cornelio Uderzo, Maria Albina Galli, Valentino Conteir, Momcilo Jankovic, Giuseppe Masera
Publikováno v:
Leukemialymphoma. 1(3-4)
Nineteen children with acute lymphoblastic leukemia (ALL) and 11 with acute non-lymphoblastic leukemia (ANLL) in first or subsequent hematological relapse, and previously exposed to high doses of anthracyclines, were treated with Epirubicin. Eleven p